IRIS
Granata, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 755
NA - Nord America 544
AS - Asia 127
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.432
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 539
IE - Irlanda 465
SE - Svezia 207
SG - Singapore 66
CN - Cina 52
IT - Italia 43
DE - Germania 11
FI - Finlandia 6
CZ - Repubblica Ceca 5
CA - Canada 4
JP - Giappone 4
RU - Federazione Russa 4
CL - Cile 3
FR - Francia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
NL - Olanda 2
NO - Norvegia 2
TH - Thailandia 2
AT - Austria 1
AU - Australia 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
MD - Moldavia 1
MK - Macedonia 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
UA - Ucraina 1
Totale 1.432
Salva come PNG Salva come JPEG
Città #
Dublin 465
Nyköping 175
Chandler 102
Ashburn 72
Princeton 48
Singapore 37
Wilmington 28
Los Angeles 22
Boardman 20
Des Moines 19
Washington 15
Munich 8
Helsinki 6
New York 6
Cape Coral 5
Guangzhou 5
Bari 4
Brno 4
Genova 4
Vittuone 4
Naples 3
San Severo 3
Shanghai 3
Wuhan 3
Bangkok 2
Chicago 2
Clifton 2
Crotone 2
Foggia 2
Fukuoka 2
Garden City 2
Kemerovo 2
Meina 2
Milan 2
Montréal 2
Norwalk 2
Paris 2
Rome 2
Shenzhen 2
Toronto 2
Turin 2
Vibo Valentia 2
Altamura 1
Andover 1
Baltimore 1
Beijing 1
Bezons 1
Birmingham 1
Bologna 1
Central 1
Chianciano Terme 1
Chisinau 1
Clearwater 1
Cupertino 1
Dalian 1
Hanover 1
Jiaxing 1
Laurel 1
Mountain View 1
Nantong 1
Newark 1
Novokuznetsk 1
Olomouc 1
Padova 1
Pune 1
Quanzhou 1
Rozendaal 1
Saint Paul 1
San Jose 1
San Salvador 1
Seattle 1
Shaoxing 1
Tappahannock 1
Weifang 1
Wuhu 1
Yiwu 1
Totale 1.131
Salva come PNG Salva come JPEG
Nome #
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 52
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 48
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen 48
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients 45
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 45
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 43
Analysis of urinary exosomes applications for rare kidney disorders 43
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 42
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase 42
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients 42
Dialysis-related transcriptomic profiling: The pivotal role of heparanase 41
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 40
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients 40
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 40
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 39
Kidney Allograft Fibrosis: What We Learned From Latest Translational Research Studies 38
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation 37
Dialysis-related systemic microinflammation is associated with specific genomic patterns 36
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 36
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 33
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 33
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells 32
Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants 29
A Comprehensive Proteomics Analysis of Urinary Extracellular Vesicles Identifies a Specific Kinase Protein Profile as a Novel Hallmark of Medullary Sponge Kidney Disease 28
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells 25
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors 25
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease 25
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease 24
Proteomics insights into medullary sponge kidney (MSK) disease: review of the recent results of an Italian research collaborative network 23
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation 23
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients 23
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets 23
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 22
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis 21
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 21
Mitochondria: a new therapeutic target in chronic kidney disease 21
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury 21
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease 20
Monoclonal antibody therapy and renal transplantation: focus on adverse effects 20
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine 19
mTOR inhibitors and renal allograft: Yin and Yang 19
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease 19
Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis 19
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings 19
mTOR Inhibition Role in Cellular Mechanisms 18
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 18
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease 18
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients 17
Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury 17
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition 17
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients 17
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 17
Association between NLRP3 rs10754558 and CARD8 rs2043211 Variants and Susceptibility to Chronic Kidney Disease 12
mRNA as a medicine in nephrology: the future is now. 11
mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation 10
Skin cancer in solid organ transplant recipients: still an open problem 8
Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease 7
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. 7
Inflammasome pathway in kidney transplantation 6
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 6
Proteomic analysis of urinary extracellular vesicles of kidney transplant recipients with BKV viruria and viremia: A pilot study 6
Proteomics reveals specific biological changes induced by the normothermic machine perfusion of donor kidneys with a significant up-regulation of Latexin 6
Immune abnormalities in IgA nephropathy 5
Totale 1.607
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.090
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022316 0 0 0 0 0 0 55 24 40 115 1 81
2022/2023937 83 19 37 10 44 84 3 106 497 6 32 16
2023/2024257 22 8 20 6 24 78 0 1 0 14 0 84
2024/202597 48 13 11 13 12 0 0 0 0 0 0 0
Totale 1.607